|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
paresthesias |
|
petechiae |
|
porphyria |
|
pruritus |
|
rash (unspecified) |
|
torticollis |
|
urine discoloration |
|
agitation |
|
amnesia |
|
anaphylactoid reactions |
|
anemia |
|
angioedema |
|
anorexia |
|
cholestasis |
|
constipation |
|
diarrhea |
|
dizziness |
|
drowsiness |
|
dysarthria |
|
dyspepsia |
|
ecchymosis |
|
elevated hepatic enzymes |
|
headache |
|
hepatic failure |
|
hepatic necrosis |
|
hepatitis |
|
jaundice |
|
malaise |
|
nausea/vomiting |
|
neutropenia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
CNS depression |
|
driving or operating machinery |
|
elderly |
|
fever |
|
neurological disease |
|
pregnancy |
|
renal failure |
|
renal impairment |
|
|
ADULT DOSE:
|
|
Skeletal muscle relaxant-
Oral, 250 to 750 mg three or four times a day; usually 500 mg three or four times a day initially and increased or decreased as determined by patient response. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Skeletal muscle relaxant-
Oral, 20 mg per kg of body weight or 600 mg per square meter of body surface, in three or four divided doses; or 125 to 500 mg three or four times a day, according to the child's age and weight. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|